葡萄糖像-1受体激动剂对老年妇女体质组成的可变影响
Arshad Mohammed1, Sneha Mishra2
1Mayo Clinic Alix School of Medicine, Mayo Clinic College of Medicine and Science, Phoenix, Arizona.
AACE endocrinology and diabetes
|February 5, 2026
概括
类似葡萄糖-1受体激动剂 (GLP-1RA) 可以影响老年人的身体组成. 运动和饮食等生活方式因素可能会在GLP-1 RA治疗期间影响瘦体质的变化.
科学领域:
- 内分泌学 在内分泌学.
- 老年病的医生 老年病的医生
- 代谢健康 代谢健康
背景情况:
- 葡萄糖类-1受体激动剂 (GLP-1RA) 已被确立为血糖控制,减肥和心血管益处.
- GLP-1RA对瘦身质量的影响,特别是在老年人群中,仍然是正在进行的研究领域.
- 本报告检查了两名接受GLP-1RA治疗的老年妇女的身体组成变化.
研究的目的:
- 描述GLP-1RA对两个老年女性的身体组成,特别是瘦身质量的影响.
- 探索在GLP-1 RA治疗期间影响瘦身量变化的潜在生活方式因素.
主要方法:
- 病例报告详细介绍了两名肥胖的老年妇女在GLP-1RA治疗前后的身体组成测量.
- 患者1: 65岁的女性,注射了蒂尔泽帕提德,持续时间为4个月.
- 患者2: 79岁女性,注射西马格卢提德,持续6个月.
主要成果:
- 这两位患者的BMI和脂肪量均有所减少.
- 一号患者的瘦肉量显著减少;二号患者的瘦肉量略有增加.
- 瘦肉量变化的差异与身体活动水平和饮食跟踪精度的变化相关.
结论:
- 在使用GLP-1RA的老年人中,个性化的运动和饮食策略可能对保持瘦身量至关重要.
- 常规的身体成分评估可以帮助指导干预和优化结果.
- 由于样本规模较小,这些发现是事性的,不能概括.
相关概念视频
Glucagon-like Receptor Agonists
980
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
980
Composite Bodies
1.4K
A composite body is a body made up of multiple parts, connected to form a larger, unified object. Each part has its own weight and center of gravity, which must be considered to determine the center of gravity of the composite body. In cases where the density or specific weight is constant, the center of gravity coincides with the centroid.
Composite bodies have widespread applications in mechanical engineering, from automobiles to aircraft to rockets. For example, an automobile wheel comprises...
Composite bodies have widespread applications in mechanical engineering, from automobiles to aircraft to rockets. For example, an automobile wheel comprises...
1.4K
Composition of Body Fluids
2.6K
Water functions as a solvent accommodating various solutes, which can be categorized under electrolytes and non-electrolytes. Non-electrolytes are usually held together by covalent bonds, restricting them from dissociating in solution, thereby leading to a lack of electrically charged components upon dissolving in water. They are predominantly organic molecules, such as glucose, creatinine, and urea. Electrolytes, on the other hand, are compounds that can break down into ions in water.
2.6K
Drug-Receptor Interaction: Agonist
4.1K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
4.1K
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
1.0K
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
1.0K
Hypoglycemia and Glucagon
990
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
990


